One-year efficacy of etanercept in ankylosing spondylitis

被引：0
|
作者：
Davis, JC
Van der Heijde, DM
Braun, J
Dougados, M
Cush, JJ
Clegg, DO
Kivitz, AJ
Inman, RD
Solinger, A
Whitmore, J
Tsuji, W
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Hosp Maastricht, Maastricht, Netherlands
[3] Rheumazentrum Ruhrgebiet, Herne, Germany
[4] Hop Cochin, F-75674 Paris, France
[5] Presbyterian Med Ctr, Dallas, TX USA
[6] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA
[7] Altoona Ctr Clin Res, Duncansville, TX USA
[8] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[9] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [31] Clinical Efficacy of Etanercept Versus Sulfasalazine in Ankylosing Spondylitis Subjects with Peripheral Joint Involvement
    Braun, Juergen
    Pavelka, Karel
    Ramos-Remus, Cesar
    Dimic, Aleksandar
    Vlahos, Bonnie
    Freundlich, Bruce
    Koenig, Andrew S.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (04) : 836 - 840
  • [32] Rapid remission of treatment-resistant ankylosing spondylitis with etanercept - a drug for refractory ankylosing spondylitis?
    Barthel, HR
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2001, 45 (04): : 404 - 404
  • [33] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: ONE-YEAR RESULTS FROM A PHASE 3 STUDY
    Baraliakos, X.
    Van der Heijde, D.
    Sieper, J.
    Inman, R.
    Kameda, H.
    Li, Y.
    Bu, X.
    Shmagel, A.
    Wung, P.
    Song, I. H.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 887 - 888
  • [34] EARLY REFERRAL OF ANKYLOSING SPONDYLITIS PATIENTS: RESULTS OF ONE YEAR OUTCOME OF A SPECIALIZED EARLY ANKYLOSING SPONDYLITIS CLINIC
    El Miedany, Yasser
    Palmer, Deborah
    RHEUMATOLOGY, 2011, 50 : 145 - 145
  • [35] One Year of Pilates Training for Ankylosing Spondylitis: A Pilot Study
    Sonsoles Rodriguez-Lopez, Elena
    Eugenia Garnacho-Garnacho, Victoria
    Guodemar-Perez, Jesus
    Garcia-Fernandez, Pablo
    Ruiz-Lopez, Montserrat
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (10) : 1054 - 1061
  • [36] Multifocal Inflammatory Lesions in Ankylosing Spondylitis Patients Depicted by Whole Body MRI (WBMRI) Improve by a One Year Therapy with Etanercept
    Karpitschka, Martina
    Theisen, Daniel
    Horng, Annie
    Glaser, Christian
    Reiser, Maximilian
    Weckbach, Sabine
    Kellner, Herbert
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S517 - S517
  • [37] The economic impact of etanercept and infliximab treatment in ankylosing spondylitis
    Duff, SB
    Yeh, Y
    Yu, EB
    Woolley, JM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 400 - 400
  • [38] The effects of etanercept on the functional status of subjects with ankylosing spondylitis
    van der Heijde, DM
    Woolley, JM
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 243 - 244
  • [39] Etanercept in adult patients with early onset ankylosing spondylitis
    Inman, Robert D.
    Clegg, Daniel O.
    Davis, John C.
    Whitmore, James B.
    Solinger, Alan
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (08) : 1634 - 1636
  • [40] New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate
    Davis, JC
    Huang, F
    Maksymowych, W
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (03) : 481 - +
12345